Cargando…

Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies

BACKGROUND: Rheumatoid arthritis (RA) treatment paradigms have shifted over the last two decades. There has been increasing emphasis on combination disease modifying anti-rheumatic drug (DMARD) therapy, newer biologic therapies have become available and there is a greater focus on achieving remissio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mian, Aneela N, Ibrahim, Fowzia, Scott, Ian C, Bahadur, Sardar, Filkova, Maria, Pollard, Louise, Steer, Sophia, Kingsley, Gabrielle H, Scott, David L, Galloway, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730644/
https://www.ncbi.nlm.nih.gov/pubmed/26818465
http://dx.doi.org/10.1186/s12891-016-0897-y
_version_ 1782412437353398272
author Mian, Aneela N
Ibrahim, Fowzia
Scott, Ian C
Bahadur, Sardar
Filkova, Maria
Pollard, Louise
Steer, Sophia
Kingsley, Gabrielle H
Scott, David L
Galloway, James
author_facet Mian, Aneela N
Ibrahim, Fowzia
Scott, Ian C
Bahadur, Sardar
Filkova, Maria
Pollard, Louise
Steer, Sophia
Kingsley, Gabrielle H
Scott, David L
Galloway, James
author_sort Mian, Aneela N
collection PubMed
description BACKGROUND: Rheumatoid arthritis (RA) treatment paradigms have shifted over the last two decades. There has been increasing emphasis on combination disease modifying anti-rheumatic drug (DMARD) therapy, newer biologic therapies have become available and there is a greater focus on achieving remission. We have evaluated the impact of treatment changes on disease activity scores for 28 joints (DAS28) and disability measured by the health assessment questionnaire scores (HAQ). METHODS: Four cross-sectional surveys between 1996 and 2014 in two adjacent secondary care rheumatology departments in London evaluated changes in drug therapy, DAS28 and its component parts and HAQ scores (in three surveys). Descriptive statistics used means and standard deviations (SD) or medians and interquartile ranges (IQR) to summarise changes. Spearman’s correlations assessed relationships between assessments. RESULTS: 1324 patients were studied. Gender ratios, age and mean disease duration were similar across all cohorts. There were temporal increases in the use of any DMARDs (rising from 61 % to 87 % of patients from 1996-2014), combination DMARDs (1 % to 41 %) and biologic (0 to 32 %). Mean DAS28 fell (5.2 to 3.7), active disease (DAS28 > 5.1) declined (50 % to 18 %) and DAS28 remission (DAS28 < 2.6) increased (8 % to 28 %). In contrast HAQ scores were unchanged (1.30 to 1.32) and correlations between DAS28 and HAQ weakened (Spearman’s rho fell from 0.56 to 0.44). CONCLUSIONS: Treatment intensity has increased over time, disease activity has fallen and there are more remissions. However, these improvements in controlling synovitis have not resulted in comparable reductions in disability measured by HAQ. As a consequence the relationship between DAS28 and HAQ has become weaker over time. Although the reasons for this divergence between disease activity and disability are uncertain, focussing treatment entirely in suppressing synovitis may be insufficient.
format Online
Article
Text
id pubmed-4730644
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47306442016-01-29 Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies Mian, Aneela N Ibrahim, Fowzia Scott, Ian C Bahadur, Sardar Filkova, Maria Pollard, Louise Steer, Sophia Kingsley, Gabrielle H Scott, David L Galloway, James BMC Musculoskelet Disord Research Article BACKGROUND: Rheumatoid arthritis (RA) treatment paradigms have shifted over the last two decades. There has been increasing emphasis on combination disease modifying anti-rheumatic drug (DMARD) therapy, newer biologic therapies have become available and there is a greater focus on achieving remission. We have evaluated the impact of treatment changes on disease activity scores for 28 joints (DAS28) and disability measured by the health assessment questionnaire scores (HAQ). METHODS: Four cross-sectional surveys between 1996 and 2014 in two adjacent secondary care rheumatology departments in London evaluated changes in drug therapy, DAS28 and its component parts and HAQ scores (in three surveys). Descriptive statistics used means and standard deviations (SD) or medians and interquartile ranges (IQR) to summarise changes. Spearman’s correlations assessed relationships between assessments. RESULTS: 1324 patients were studied. Gender ratios, age and mean disease duration were similar across all cohorts. There were temporal increases in the use of any DMARDs (rising from 61 % to 87 % of patients from 1996-2014), combination DMARDs (1 % to 41 %) and biologic (0 to 32 %). Mean DAS28 fell (5.2 to 3.7), active disease (DAS28 > 5.1) declined (50 % to 18 %) and DAS28 remission (DAS28 < 2.6) increased (8 % to 28 %). In contrast HAQ scores were unchanged (1.30 to 1.32) and correlations between DAS28 and HAQ weakened (Spearman’s rho fell from 0.56 to 0.44). CONCLUSIONS: Treatment intensity has increased over time, disease activity has fallen and there are more remissions. However, these improvements in controlling synovitis have not resulted in comparable reductions in disability measured by HAQ. As a consequence the relationship between DAS28 and HAQ has become weaker over time. Although the reasons for this divergence between disease activity and disability are uncertain, focussing treatment entirely in suppressing synovitis may be insufficient. BioMed Central 2016-01-27 /pmc/articles/PMC4730644/ /pubmed/26818465 http://dx.doi.org/10.1186/s12891-016-0897-y Text en © Mian et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mian, Aneela N
Ibrahim, Fowzia
Scott, Ian C
Bahadur, Sardar
Filkova, Maria
Pollard, Louise
Steer, Sophia
Kingsley, Gabrielle H
Scott, David L
Galloway, James
Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies
title Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies
title_full Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies
title_fullStr Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies
title_full_unstemmed Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies
title_short Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies
title_sort changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730644/
https://www.ncbi.nlm.nih.gov/pubmed/26818465
http://dx.doi.org/10.1186/s12891-016-0897-y
work_keys_str_mv AT miananeelan changingclinicalpatternsinrheumatoidarthritismanagementovertwodecadessequentialobservationalstudies
AT ibrahimfowzia changingclinicalpatternsinrheumatoidarthritismanagementovertwodecadessequentialobservationalstudies
AT scottianc changingclinicalpatternsinrheumatoidarthritismanagementovertwodecadessequentialobservationalstudies
AT bahadursardar changingclinicalpatternsinrheumatoidarthritismanagementovertwodecadessequentialobservationalstudies
AT filkovamaria changingclinicalpatternsinrheumatoidarthritismanagementovertwodecadessequentialobservationalstudies
AT pollardlouise changingclinicalpatternsinrheumatoidarthritismanagementovertwodecadessequentialobservationalstudies
AT steersophia changingclinicalpatternsinrheumatoidarthritismanagementovertwodecadessequentialobservationalstudies
AT kingsleygabrielleh changingclinicalpatternsinrheumatoidarthritismanagementovertwodecadessequentialobservationalstudies
AT scottdavidl changingclinicalpatternsinrheumatoidarthritismanagementovertwodecadessequentialobservationalstudies
AT gallowayjames changingclinicalpatternsinrheumatoidarthritismanagementovertwodecadessequentialobservationalstudies